NCT07405476 2026-04-17
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Phase 2 Recruiting
Emory University
National Cancer Institute (NCI)
NRG Oncology
First Affiliated Hospital of Wenzhou Medical University
Fudan University
Centre Paul Strauss
Fudan University
Shanghai Tongji Hospital, Tongji University School of Medicine
Fudan University